Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT05293158
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥ 19 years and ≤ 80 of age
* HBsAg-positive HCC-patients scheduled for resection in ≥6 weeks or HBsAg-positive HCC- patients listed for LT
* Ability of subjects to understand character and individual consequences of the clinical trial
* Written informed consent must be available before enrolment in the trial
Exclusion Criteria:
* Clinically significant illness (other than HBV) or any other major medical disorder that, in the opinion of the investigator, may interfere with subject treatment
* No eligibility for resection / LT
* Concurrent any other malignancy
* Co-infection with hepatitis C virus (defined as HCV RNA positive, HCV RNA-negative/anti-HCV-positive patients can be included) and/or human immunodeficiency virus (HIV)
* Clinical hepatic decompensation
* Allergy to HBIG
* Pregnant, lactating patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
80 Years
Study:
NCT05293158
Study Brief:
Protocol Section:
NCT05293158